|
Originally published In Press as doi:10.1074/jbc.M306708200 on September 4, 2003
J. Biol. Chem., Vol. 278, Issue 46, 45382-45390, November 14, 2003
Tumor Necrosis Factor Receptor-associated Factor 2 (TRAF2)-deficient B Lymphocytes Reveal Novel Roles for TRAF2 in CD40 Signaling*
Bruce S. Hostager ,
Sokol A. Haxhinasto ,
Sarah L. Rowland , and
Gail A. Bishop ¶||**
From the
Department of Pediatrics, Interdisciplinary Program in Immunology, and the ¶Departments of Microbiology, Internal Medicine, University of Iowa, Iowa City and the ||Veterans Affairs Medical Center, Iowa City, Iowa 52242
CD40 function is initiated by tumor necrosis factor (TNF) receptor-associated factor (TRAF) adapter proteins, which play important roles in signaling by numerous receptors. Characterizing roles of individual TRAFs has been hampered by limitations of available experimental models and the poor viability of most TRAF-deficient mice. Here, B cell lines made deficient in TRAF2 using a novel homologous recombination system reveal new roles for TRAF2. We demonstrate that TRAF2 participates in synergy between CD40 and B cell antigen receptor signals, and in CD40-mediated, TNF-dependent IgM production. We also find that TRAF2 participates in the degradation of TRAF3 associated with CD40 signaling, a role that may limit inhibitory actions of TRAF3. Finally, we show that TRAF2 and TRAF6 have overlapping functions in CD40-mediated NF- B activation and CD80 up-regulation. These findings demonstrate previously unappreciated roles for TRAF2 in signaling by TNF receptor family members, using an approach that facilitates the analysis of genes critical to the viability of whole organisms.
Received for publication, June 24, 2003
, and in revised form, August 15, 2003.
* This work was supported by grants from the American Heart Association (to B. S. H.), by National Institutes of Health Grants AI28847 and AI49993, and by Veterans Affairs Merit Review 383 (to G. A. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
** To whom correspondence should be addressed: Dept. of Microbiology, University of Iowa, 3-570 Bowen Science Bldg., 51 Newton Rd., Iowa City, IA. 52242. Tel.: 319-335-7945; Fax: 319-335-9006; E-mail: gail-bishop{at}uiowa.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. M. Zapata, D. Llobet, M. Krajewska, S. Lefebvre, C. L. Kress, and J. C. Reed
Lymphocyte-specific TRAF3 transgenic mice have enhanced humoral responses and develop plasmacytosis, autoimmunity, inflammation, and cancer
Blood,
May 7, 2009;
113(19):
4595 - 4603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Jabara, Y. Weng, T. Sannikova, and R. S. Geha
TRAF2 and TRAF3 independently mediate Ig class switching driven by CD40
Int. Immunol.,
April 1, 2009;
21(4):
477 - 488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Dupoux, J. Cartier, S. Cathelin, R. Filomenko, E. Solary, and L. Dubrez-Daloz
cIAP1-dependent TRAF2 degradation regulates the differentiation of monocytes into macrophages and their response to CD40 ligand
Blood,
January 1, 2009;
113(1):
175 - 185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Han and K. Yu
Altered kinetics of nonhomologous end joining and class switch recombination in ligase IV-deficient B cells
J. Exp. Med.,
November 24, 2008;
205(12):
2745 - 2753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Guasparri, D. Bubman, and E. Cesarman
EBV LMP2A affects LMP1-mediated NF-{kappa}B signaling and survival of lymphoma cells by regulating TRAF2 expression
Blood,
April 1, 2008;
111(7):
3813 - 3820.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Hovelmeyer, F. T. Wunderlich, R. Massoumi, C. G. Jakobsen, J. Song, M. A. Worns, C. Merkwirth, A. Kovalenko, M. Aumailley, D. Strand, et al.
Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD
J. Exp. Med.,
October 29, 2007;
204(11):
2615 - 2627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Qiao, M. Lei, Z. Li, Y. Sun, A. Minto, Y.-X. Fu, H. Ying, R. J. Quigg, and J. Zhang
Negative Regulation of CD40-Mediated B Cell Responses by E3 Ubiquitin Ligase Casitas-B-Lineage Lymphoma Protein-B
J. Immunol.,
October 1, 2007;
179(7):
4473 - 4479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Rowland, M. M. Tremblay, J. M. Ellison, L. L. Stunz, G. A. Bishop, and B. S. Hostager
A Novel Mechanism for TNFR-Associated Factor 6-Dependent CD40 Signaling
J. Immunol.,
October 1, 2007;
179(7):
4645 - 4653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Zirlik, U. Bavendiek, P. Libby, L. MacFarlane, N. Gerdes, J. Jagielska, S. Ernst, M. Aikawa, H. Nakano, E. Tsitsikov, et al.
TRAF-1, -2, -3, -5, and -6 Are Induced in Atherosclerotic Plaques and Differentially Mediate Proinflammatory Functions of CD40L in Endothelial Cells
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2007;
27(5):
1101 - 1107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Munroe and G. A. Bishop
A Costimulatory Function for T Cell CD40
J. Immunol.,
January 15, 2007;
178(2):
671 - 682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Xie, B. S. Hostager, M. E. Munroe, C. R. Moore, and G. A. Bishop
Cooperation between TNF Receptor-Associated Factors 1 and 2 in CD40 Signaling
J. Immunol.,
May 1, 2006;
176(9):
5388 - 5400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. He, X. Wu, R. Siegel, and P. E. Lipsky
TRAF6 Regulates Cell Fate Decisions by Inducing Caspase 8-dependent Apoptosis and the Activation of NF-{kappa}B
J. Biol. Chem.,
April 21, 2006;
281(16):
11235 - 11249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Davies, T. W. Mak, L. S. Young, and A. G. Eliopoulos
TRAF6 Is Required for TRAF2-Dependent CD40 Signal Transduction in Nonhemopoietic Cells
Mol. Cell. Biol.,
November 15, 2005;
25(22):
9806 - 9819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Moore and G. A. Bishop
Differential Regulation of CD40-Mediated TNF Receptor-Associated Factor Degradation in B Lymphocytes
J. Immunol.,
September 15, 2005;
175(6):
3780 - 3789.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Qin, Y. Qian, J. Yao, C. Grace, and X. Li
SIGIRR Inhibits Interleukin-1 Receptor- and Toll-like Receptor 4-mediated Signaling through Different Mechanisms
J. Biol. Chem.,
July 1, 2005;
280(26):
25233 - 25241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lamkanfi, K. D'hondt, L. Vande Walle, M. van Gurp, G. Denecker, J. Demeulemeester, M. Kalai, W. Declercq, X. Saelens, and P. Vandenabeele
A Novel Caspase-2 Complex Containing TRAF2 and RIP1
J. Biol. Chem.,
February 25, 2005;
280(8):
6923 - 6932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-P. Xia and Z. J. Chen
TRAF2: A Double-Edged Sword?
Sci. Signal.,
February 22, 2005;
2005(272):
pe7 - pe7.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Mukundan, G. A. Bishop, K. Z. Head, L. Zhang, L. M. Wahl, and J. Suttles
TNF Receptor-Associated Factor 6 Is an Essential Mediator of CD40-Activated Proinflammatory Pathways in Monocytes and Macrophages
J. Immunol.,
January 15, 2005;
174(2):
1081 - 1090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. He, A. C. Grammer, X. Wu, and P. E. Lipsky
TRAF3 Forms Heterotrimers with TRAF2 and Modulates Its Ability to Mediate NF-{kappa}B Activation
J. Biol. Chem.,
December 31, 2004;
279(53):
55855 - 55865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Munroe and G. A. Bishop
Role of Tumor Necrosis Factor (TNF) Receptor-associated Factor 2 (TRAF2) in Distinct and Overlapping CD40 and TNF Receptor 2/CD120b-mediated B Lymphocyte Activation
J. Biol. Chem.,
December 17, 2004;
279(51):
53222 - 53231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Xie and G. A. Bishop
Roles of TNF Receptor-Associated Factor 3 in Signaling to B Lymphocytes by Carboxyl-Terminal Activating Regions 1 and 2 of the EBV-Encoded Oncoprotein Latent Membrane Protein 1
J. Immunol.,
November 1, 2004;
173(9):
5546 - 5555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-K. Ea, L. Sun, J.-I. Inoue, and Z. J. Chen
TIFA activates I{kappa}B kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6
PNAS,
October 26, 2004;
101(43):
15318 - 15323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-H. Hu, X.-M. Mo, W. M. Walters, R. Brambilla, and J. R. Bethea
TNAP, a Novel Repressor of NF-{kappa}B-inducing Kinase, Suppresses NF-{kappa}B Activation
J. Biol. Chem.,
August 20, 2004;
279(34):
35975 - 35983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lamkanfi, M. Kalai, X. Saelens, W. Declercq, and P. Vandenabeele
Caspase-1 Activates Nuclear Factor of the {kappa}-Enhancer in B Cells Independently of Its Enzymatic Activity
J. Biol. Chem.,
June 4, 2004;
279(23):
24785 - 24793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Xie, B. S. Hostager, and G. A. Bishop
Requirement for TRAF3 in Signaling by LMP1 But Not CD40 in B Lymphocytes
J. Exp. Med.,
March 1, 2004;
199(5):
661 - 671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Haxhinasto and G. A. Bishop
Synergistic B Cell Activation by CD40 and the B Cell Antigen Receptor: ROLE OF B LYMPHOCYTE ANTIGEN RECEPTOR-MEDIATED KINASE ACTIVATION AND TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTOR REGULATION
J. Biol. Chem.,
January 23, 2004;
279(4):
2575 - 2582.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|